Evaluation of the Efficiency of the Magicramp® Device for Reducing Cramps Resulting from Oncological Treatments: “Double-Blind, Randomized Clinical Trial”
We identified that oncological treatments in general (chemotherapies, immunotherapies and radiotherapies) frequently cause peripheral neuropathy, including cramps, characterized by excess protons due to metabolic and neuronal factors, such as sudden changes in pH, uremia and aspects that affect neuromotor functions. Such situations and others like them are often neglected in treatment, which naturally concerns itself with the main problem: Cancer. Sometimes toxic solutions are implemented that have comorbid side effects, such as duloxetine (standard treatment). Based on monitoring of cancer patients who used the non-toxic product, called “Magicramp？ Electrostatic Charge Reduction Cushion” (MECRC), approved in Europe more than 10 years ago, we carried out a controlled test in Brazil. In this clinical trial, we hypothesized that reducing excessive ionic charges (electrostatic charge), which is one of the side effects often described in the literature as “Chemotherapy-Induced Peripheral Neuropathy” (CIPN), would decrease or eliminate cramping, under the hypothesis that such elimination would prevent or attenuate muscular vulnerability to action impulses, and increase the power of relaxation through the same mechanism. In this double-blind and randomized clinical trial, 40 (forty) adult patients with muscle cramps caused by oncological treatments were tested, evaluating the degree of efficiency of the product that aims to reduce muscle cramps, by eliminating and/or reducing excess loads electrostatic ionic. Data from the clinical research conducted in this study are available online.
References
[1]
REBEC-Brazilian Clinical Trial Registry-RBR-377gqvx (2015) Brazilian Clinical Trials Registry/Registro Brasileiro de Ensaios Clínicas.
Noll, C.G. (2000) Balanced Static Elimination in Variable Ion Mobility Environments. Journal of Electrostatics, 49, 169-194. https://doi.org/10.1016/S0304-3886(00)00017-6
[4]
Inaba, H., Ohmi, T., Yoshida, T. and Okada, T. (1994) Neutralization of Static Electricity by Soft X-Rays and Vacuum UV Radiation. Journal of Electrostatics, 33, 15-42. https://doi.org/10.1016/0304-3886(94)90061-2
[5]
Kulkarni, P., Namiki, N., Otani, Y. and Biswas, P. (2002) Charging of Particles in Unipolar Coronas Irradiated by in-situ Soft X-Rays: Enhancement of Capture Efficiency of Ultrafine Particles. Journal of Aerosol Science, 33, 1279-1296. https://doi.org/10.1016/S0021-8502(02)00067-8
[6]
Kachi, M. and Dascalescu, L. (2014) Corona Discharges in Asymmetric Electrode Configurations. Journal of Electrostatics, 72, 6-12. https://doi.org/10.1016/j.elstat.2013.11.001
[7]
Greason, W.D. (2007) Review of Charge and Potential Control of Electrostatic Discharge (ESD) in Microdevices. IEEE Transactions on Industry Applications, 43, 1149-1158. https://doi.org/10.1109/TIA.2007.904366
[8]
ICD10 International Classification of Diseases. https://cid10.com.br/
[9]
ICD-11 for Mortality and Morbidity Statistics. https://icd.who.int/en
[10]
MeSH Linked Data. https://id.nlm.nih.gov/mesh/
[11]
Medical Subject Headings RDF. https://id.nlm.nih.gov/mesh/
[12]
Colvin, L.A. (2019) Chemotherapy-Induced Peripheral Neuropathy (CIPN): Where Are We Now? PAIN, 160, S1-S10. https://doi.org/10.1097/j.pain.0000000000001540
[13]
Park, H.J. (2014) Chemotherapy Induced Peripheral Neuropathic Pain. Korean Journal of Anesthesiology, 67, 4-7. https://doi.org/10.4097/kjae.2014.67.1.4
[14]
Kaur, S. and Muthuraman, A. (2019) Ameliorative Effect of Gallic Acid in Paclitaxel-Induced Neuropathic Pain in Mice. Toxicology Reports, 6, 505-513. https://doi.org/10.1016/j.toxrep.2019.06.001
[15]
Marco Alessandro, M., Aleš, H., Alberto, B. and Dario, F. (2013) Origin and Development of Muscle Cramps. Exercise and Sport Sciences Reviews, 4, 3-10. https://doi.org/10.1097/JES.0b013e3182724817
[16]
Giuriato, G., Pedrinolla, A., Schena, F. and Venturelli, M. (2018) Muscle Cramps: A Comparison of the Two-Leading Hypothesis. Journal of Electromyography and Kinesiology, 41, 89-95. https://doi.org/10.1016/j.jelekin.2018.05.006
[17]
Kumar, J., Joshi, H. and Malyan, S.K. (2021) Removal of Copper, Nickel, and Zinc Ions from an Aqueous Solution through Electrochemical and Nanofiltration Membrane Processes. Applied Sciences, 12, Article 280. https://doi.org/10.3390/app12010280
[18]
Minetto, M.A., Botter, A., De Grandis, D. and Merletti, R. (2009) Time and Frequency Domain Analysis of Surface Myoelectric Signals during Electrically-Elicited Cramps. Neurophysiologie Clinique/Clinical Neurophysiology, 39, 15-25. https://doi.org/10.1016/j.neucli.2008.11.002
[19]
Minetto, M.A., Botter, A., Ravenni, R., Merletti, R. and De Grandis, D. (2008) Reliability of a Novel Neurostimulation Method to Study Involuntary Muscle Phenomena. Muscle & Nerve, 37, 90-100. https://doi.org/10.1002/mus.20903
[20]
Roeleveld, K., van Engelen, B.G. and Stegeman, D.F. (2000) Possible Mechanisms of Muscle Cramp from Temporal and Spatial Surface EMG Characteristics. Journal of Applied Physiology, 88, 1698-1706. https://doi.org/10.1152/jappl.2000.88.5.1698
[21]
Bergeron, M.F. (2008) Muscle Cramps during Exercise—Is It Fatigue or Electrolyte Deficit? Current Sports Medicine Reports, 7, S50-S55. https://doi.org/10.1249/JSR.0b013e31817f476a
[22]
Merletti, R., Botter, A., Troiano, A., Merlo, E. and Minetto, M.A. (2009) Technology and Instrumentation for Detection and Conditioning of the Surface Electromyographic Signal: State of the Art. Clinical Biomechanics, 24, 122-134. https://doi.org/10.1016/j.clinbiomech.2008.08.006
[23]
Miller, K.C. and Knight, K.L. (2009) Electrical Stimulation Cramp Threshold Frequency Correlates Well with the Occurrence of Skeletal Muscle Cramps. Muscle & Nerve, 39, 364-368. https://doi.org/10.1002/mus.21170
[24]
Kalantar-Zadeh, K., Lockwood, M.B., Rhee, C.M., Tantisattamo, E., Andreoli, S., Balducci, A., Laffin, P., Harris, T. and Knight, R. (2022) Patient-Centred Approaches for the Management of Unpleasant Symptoms in Kidney Disease. Nature Reviews Nephrology, 18, 185-198. https://doi.org/10.1038/s41581-021-00518-z
[25]
Chung, K.H., Park, S.B., Streckmann, F., Wiskemann, J., Mohile, N., Kleckner, A.S., Colloca, L., Dorsey, S.G. and Kleckner, I.R. (2022) Mechanisms, Mediators, and Moderators of the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy. Cancers, 14, Article 1224. https://doi.org/10.3390/cancers14051224
[26]
Roeleveld, K., van Engelen, B.G.M. and Stegeman, D.F. (2000) Possible Mechanisms of Muscle Cramp from Temporal and Spatial Surface EMG Characteristics. Journal of Applied Physiology, 88, 1698-1706. https://doi.org/10.1152/jappl.2000.88.5.1698
[27]
Jaggi, A.S. and Singh, N. (2012) Mechanisms in Cancer-Chemotherapeutic Drugs-Induced Peripheral Neuropathy. Toxicology, 291, 1-9. https://doi.org/10.1016/j.tox.2011.10.019
[28]
Fabricius, H. (1973) Galvanism and Acupuncture an Analogue. Scandinavian Audiology, 2, 191-196. https://doi.org/10.3109/01050397309044953
[29]
Gater Jr., D.R., Dolbow, D., Tsui, B. and Gorgey, A.S. (2011) Functional Electrical Stimulation Therapies after Spinal Cord Injury. NeuroRehabilitation, 28, 231-248. https://doi.org/10.3233/NRE-2011-0652
Saito, T., Okamura, A., Inoue, J., Makiura, D., Doi, H., Yakushijin, K., Matsuoka, H., Sakai, Y. and Ono, R. (2019) Anemia Is a Novel Predictive Factor for the Onset of Severe Chemotherapy-Induced Peripheral Neuropathy in Lymphoma Patients Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone Therapy. Oncology Research, 27, 469-474. https://doi.org/10.3727/096504018X15267574931782
[32]
Siegal, T. and Haim, N. (1990) Cisplatin-Induced Peripheral Neuropathy. Frequent off-Therapy Deterioration, Demyelinating Syndromes, and Muscle Cramps. Cancer, 66, 1117-1123. https://doi.org/10.1002/1097-0142(19900915)66:6<1117::AID-CNCR2820660607>3.0.CO;2-O
[33]
Haim, N., Barron, S.A. and Robinson, E. (1991) Muscle Cramps Associated with Vincristine Therapy. Acta Oncologica, 30, 707-711. https://doi.org/10.3109/02841869109092444
[34]
Maxwell, S.K., Kokokyi, S., Breiner, A., Ebadi, H., Bril, V. and Katzberg, H.D. (2014) Characteristics of Muscle Cramps in Patients with Polyneuropathy. Neuromuscular Disorders, 24, 671-676. https://doi.org/10.1016/j.nmd.2014.04.008
[35]
Doherty, N., Hancock, S.L., Kaye, S., Norman C.C., Shulman, L., Marquez, C., Mariscal, C., Rampling, R. and Senan, S. (1994) Muscle Cramping in Phase i Clinical Trials of Tirapazamine (SR 4233) with and without Radiation. International Journal of Radiation Oncology∙Biology∙Physics, 29, 379-382. https://doi.org/10.1016/0360-3016(94)90293-3
[36]
Toale, K.M., Johnson, T.N., Ma, M.Q. and Vu, N.H. (2021) Chemotherapy Toxicities. In: Todd, K.H., Thomas Jr., C.R. and Alagappan, K., Eds., Oncologic Emergency Medicine, Springer, Cham, 637-661. https://doi.org/10.1007/978-3-030-67123-5_48
[37]
Norris, F.H., Gasteiger, E.L. and Chatfield, P.O. (1957) An Electromyographic Study of Induced and Spontaneous Muscle Cramps. Electroencephalography and Clinical Neurophysiology, 9, 139-147. https://doi.org/10.1016/0013-4694(57)90118-9
[38]
Harmsen, J.-F., Latella, C., Mesquita, R., Fasse, A., Schumann, M., Behringer, M., Taylor, J. and Nosaka, K. (2021) H-Reflex and M-Wave Responses after Voluntary and Electrically Evoked Muscle Cramping. European Journal of Applied Physiology, 121, 659-672. https://doi.org/10.1007/s00421-020-04560-w
[39]
Mehta, T., Sommers, R. and Govindarajan, R. (2021) Efficacy of Botulinum Toxin for Treating Cramps in Peripheral Neuropathy. RRNMF Neuromuscular Journal, 2, 19-22. https://doi.org/10.17161/rrnmf.v2i3.14951
[40]
Behringer, M., Link, T.W., Montag, J.C.K., McCourt, M.L. and Mester, J. (2015) Are Electrically Induced Muscle Cramps Able to Increase the Cramp Threshold Frequency, When Induced Once a Week? Orthopedic Reviews, 7, 55-59. https://doi.org/10.4081/or.2015.6028
[41]
Ferreira, L.S., Motta, M.P., Helou, A.S., Portes, L.A., Fávero, F.M., Oliveira, A.S.B. and dos Santos, V.R. (2019) Study of Technology for the Reduction of Ionic Charges (Static Charges) in the Human Body. Cadernos de Pós-GraduaçãoemDoenças da Desenvolvimento,
[42]
Motta, M.P., Campos, K.M., Quadros, A.J., Oliveira, A.S.B., Favero, F.M. and dos Santos, V.R. (2019) Redução de cargas iônicas na intolerância ao frio em pacientes com síndrome pós poliomielite. Revista da Universidade Ibirapuera,
[43]
Y., Leung, A. K. Wong, B. E. Chan, P. Y. Cho, H. (1999) Nocturnal Leg Cramps in Children: Incidence and Clinical Characteristics. Journal of the National Medical Association, 91, 329-332.
[44]
Kulkarni, M. (2003) Disorders Due to Spasm or Cramps of Muscles. In: Mathur, G.P. and Mathur, S., Eds., Movement Disorders in Children & Adolescents, Jaypee Brothers Medical Publishers (P) Ltd., New Delhi, 86-86. https://doi.org/10.5005/jp/books/11612_10
[45]
Gallone, P. (1986) Galvani’s Frog: Harbinger of a New Era. Electrochimica Acta, 31, 1485-1490. https://doi.org/10.1016/0013-4686(86)87065-7
[46]
Bresadola, M. (1998) Medicine and Science in the Life of Luigi Galvani (1737-1798). Brain Research Bulletin, 46, 367-380. https://doi.org/10.1016/S0361-9230(98)00023-9
[47]
Chevalier, G., Sinatra, S.T., Oschman, J.L., Sokal, K. and Sokal, P. (2012) Earthing: Health Implications of Reconnecting the Human Body to the Earth’s Surface Electrons. Journal of Environmental and Public Health, 2012, Article ID: 291541. https://doi.org/10.1155/2012/291541
[48]
Oschman, J.L., Chevalier, G. and Brown, R. (2015) The Effects of Grounding (Earthing) on Inflammation, the Immune Response, Wound Healing, and Prevention and Treatment of Chronic Inflammatory and Autoimmune Diseases. Journal of Inflammation Research, 8, 83-96. https://doi.org/10.2147/JIR.S69656
[49]
Chevalier, G., Melvin, G. and Barsotti, T. (2015) One-Hour Contact with the Earth’s Surface (Grounding) Improves Inflammation and Blood Flow—A Randomized, Double-Blind, Pilot Study. Health, 7, 1022-1059. https://doi.org/10.4236/health.2015.78119
[50]
Clinton, O. (2014) Earthing: The Most Important Health Discovery Ever! Basic Health Publications Inc., Laguna Beach.
[51]
Chevalier, G. (2014) Grounding the Human Body Improves Facial Blood Flow Regulation: Results of a Randomized, Placebo Controlled Pilot Study. Journal of Cosmetics, Dermatological Sciences and Applications, 4, 293-308. https://doi.org/10.4236/jcdsa.2014.45039
[52]
Magicramp. https://magicramp.com.br/
[53]
Nielsen, V.K. (1973) The Peripheral Nerve Function in Chronic Renal Failure. Acta Medica Scandinavica, 194, 445-454. https://doi.org/10.1111/j.0954-6820.1973.tb19470.x
[54]
Mallipeddi, S., Jasti, D.B., Apparao, A., Vengamma, B., Sivakumar, V. and Kolli, S. (2018) A Clinical and Electrophysiological Study of Peripheral Neuropathies in Peritoneal Dialysis Patients: Our Experience from Rural South India. Saudi Journal of Kidney Diseases and Transplantation, 29, 1139-1149. https://doi.org/10.4103/1319-2442.243942
[55]
Arnold, R., Pianta, T.J., Issar, T., Kirby, A., Scales, C.M.K., Kwai, N.C.G., Endre, Z. and Krishnan, A.V. (2022) Peripheral Neuropathy: An Important Contributor to Physical Limitation and Morbidity in Stages 3 and 4 Chronic Kidney Disease. Nephrology Dialysis Transplantation, 37, 713-719. https://doi.org/10.1093/ndt/gfab043
[56]
Vanholder, R. (1998) Pathogenesis of Uremic Toxicity. In: Ronco, C. and Bellomo, R., Eds., Critical Care Nephrology, Springer, Dordrecht, 845-853. https://doi.org/10.1007/978-94-011-5482-6_70
Werneck, L.C., Mulinari, A.S., Laffite, A. and Kesikowski, L.B. (1979) Polineuropatia urêmica: Estudo clínico-eletroneurográfico de 33 casos. Arquivos de Neuro-Psiquiatria, 37, 356-372. https://doi.org/10.1590/S0004-282X1979000400002
[59]
Krishnan, A.V. and Kiernan, M.C. (2009) Neurological Complications of Chronic Kidney Disease. Nature Reviews Neurology, 5, 542-551. https://doi.org/10.1038/nrneurol.2009.138
[60]
Tellioğlu, D.E.Y., Özge, A., Gençtoy, G., Horoz, M., Taşdelen, B. and Kıykım, A. (2012) Clinical and Electrophysiological Correlation of Patients with Chronic Renal Failure: The Contributions of Quantitative Neurological Scores. International Journal of Medicine and Medical Sciences, 4, 192-199.
[61]
Sokal, P., Jastrzębski, Z., Jaskulska, E., Sokal, K., Jastrzębska, M., Radzimiński, Ł., Dargiewicz, R. and Zieliński, P. (2013) Differences in Blood Urea and Creatinine Concentrations in Earthed and Unearthed Subjects during Cycling Exercise and Recovery. Evidence-Based Complementary and Alternative Medicine, 2013, Article ID: 382643. https://doi.org/10.1155/2013/382643
[62]
Behringer, M., Harmsen, J.-F., Fasse, A. and Mester, J. (2018) Effects of Neuromuscular Electrical Stimulation on the Frequency of Skeletal Muscle Cramps: A Prospective Controlled Clinical Trial. Neuromodulation: Technology at the Neural Interface, 21, 815-822. https://doi.org/10.1111/ner.12728
[63]
Harmsen, J.-F., Sistig, A., Fasse, A., Hackl, M., Wegmann, K. and Behringer, M. (2021) Neuromuscular Electrical Stimulation Reduces Leg Cramps in Patients with Lumbar Degenerative Disorders: A Randomized Placebo-Controlled Trial. Neuromodulation: Technology at the Neural Interface, 24, 1483-1492. https://doi.org/10.1111/ner.13315
[64]
Pignata, S., Pisano, C., Bruni, G.S., Facchini, G. and Pignata, S. (2009) Treatment of Recurrent Epithelial Ovarian Cancer. Therapeutics and Clinical Risk Management, 5, 421-426. https://doi.org/10.2147/tcrm.s4317
[65]
Oronsky, B., Caroen, S., Oronsky, A., Dobalian, V.E., Oronsky, N., Lybeck, M., Reid, T.R. and Carter, C.A. (2017) Electrolyte Disorders with Platinum-Based Chemotherapy: Mechanisms, Manifestations and Management. Cancer Chemotherapy and Pharmacology, 80, 895-907. https://doi.org/10.1007/s00280-017-3392-8
[66]
Tzortzatou, F., Dacou-Voutetakis, C., Haidas, S., Papadellis, F. and Thomaidis, T.H. (1979) Electrolyte Abnormalities in Lymphosarcoma after Chemotherapy. Acta Paediatrica, 68, 621-623. https://doi.org/10.1111/j.1651-2227.1979.tb05069.x
[67]
Schwellnus, M.P. (2009) Cause of Exercise Associated Muscle Cramps (EAMC)—Altered Neuromuscular Control, Dehydration or Electrolyte Depletion? British Journal of Sports Medicine, 43, 401-408. https://doi.org/10.1136/bjsm.2008.050401
[68]
Bordoni, B., Sugumar, K. and Varacallo, M. (2022) Muscle Cramps. StatPearls Publishing, Treasure Island.
[69]
Betts, J.G. (2013) Anatomy & Physiology. Peter Desaix, Eddie Johnson, Jody E. Johnson, Oksana Korol, Dean Kruse, Brandon Poe. Houston.
[70]
Hoppe, K., Sartorius, T., Chaiklieng, S., Wietzorrek, G., Ruth, P., Jurkat-Rott, K., Wearing, S., Lehmann-Horn, F. and Klingler, W. (2020) Paxilline Prevents the Onset of Myotonic Stiffness in Pharmacologically Induced Myotonia: A Preclinical Investigation. Frontiers in Physiology, 11, Article 533946. https://doi.org/10.3389/fphys.2020.533946
[71]
Ralph, J. and Ptáček, L. (2020) Muscle Channelopathies: Periodic Paralyses and Nondystrophic Myotonias. In: Rosenberg, R.N. and Pascual, J.M., Eds., Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease, Academic Press, Cambridge, 525-537. https://doi.org/10.1016/B978-0-12-813866-3.00031-X
[72]
Morgan, G., Ward, R. and Barton, M. (2004) The Contribution of Cytotoxic Chemotherapy to 5-Year Survival in Adult Malignancies. Clinical Oncology, 16, 549-560. https://doi.org/10.1016/j.clon.2004.06.007
[73]
Junqueira, M.Z. and Chammas, R. (2018) Cancer Chemotherapy Failure: A Synthetic View. Revista de Medicina, 97, 141-153.
[74]
Sawada, N.O., Nicolussi, A.C., de Paula, J.M., Garcia-Caro, M.P., Marti-Garcia, C. and Cruz-Quintana, F. (2016) Quality of Life of Brazilian and Spanish Cancer Patients Undergoing Chemotherapy: An Integrative Literature Review. Revista Latino-Americana de Enfermagem, 24, e2688. https://doi.org/10.1590/1518-8345.0564.2688
[75]
ABC News (2008) Chemotherapy Contributes to a Quarter of Cancer Deaths: Study.
[76]
Filippou, P.S. and Karagiannis, G.S. (2020) Cytokine Storm during Chemotherapy: A New Companion Diagnostic Emerges? Oncotarget, 11, 213-215. https://doi.org/10.18632/oncotarget.27442
Bupathi, M., Hajjar, J., Bean, S., Fu, S., Hong, D., Karp, D., Stephen, B., Hess, K. and Meric-Bernstam, F. (2017) Incidence of Infusion Reactions to Anti-Neoplastic Agents in Early Phase Clinical Trials: The MD Anderson Cancer Center Experience. Investigational New Drugs, 35, 59-67. https://doi.org/10.1007/s10637-016-0395-y
[79]
Desforges, A.D., Hebert, C.M., Spence, A.L., Reid, B., Dhaibar, H.A., Cruz-Topete, D., Cornett, E.M., Kaye, A.D. and Urits, I. (2022) Treatment and Diagnosis of Chemotherapy-Induced Peripheral Neuropathy: An Update. Biomedicine & Pharmacotherapy, 147, Article 112671. https://doi.org/10.1016/j.biopha.2022.112671
[80]
Hou, S., Huh, B., Kim, H.K., Kim, K.-H. and Abdi, S. (2018) Treatment of Chemotherapy-Induced Peripheral Neuropathy: Systematic Review and Recommendations. Pain Physician, 21, 571-592. https://doi.org/10.36076/ppj.2018.6.571
[81]
Wolf, S., Barton, D., Kottschade, L., Grothey, A. and Loprinzi, C. (2008) Chemotherapy-Induced Peripheral Neuropathy: Prevention and Treatment Strategies. European Journal of Cancer, 44, 1507-1515. https://doi.org/10.1016/j.ejca.2008.04.018
[82]
Nakanishi, H., Kurosaki, M., Tsuchiya, K., Nakakuki, N., Takada, H., Matsuda, S., Gondo, K., Asano, Y. and Hattori, N. (2015) L-Carnitine Reduces Muscle Cramps in Patients with Cirrhosis. Clinical Gastroenterology and Hepatology, 13, 1540-1543. https://doi.org/10.1016/j.cgh.2014.12.005
[83]
Miwa, T., Hanai, T., Morino, K., Katsumura, N. and Shimizu, M. (2020) Effect of L-Carnitine Supplementation on Muscle Cramps Induced by Stroke: A Case Report. Nutrition, 71, 110638. https://doi.org/10.1016/j.nut.2019.110638
